Vertex Pharmaceuticals (Europe) Ltd

Average Profitability
38.8%
Insider Buys Quantity
8
Insider Buys Sum
$9.56M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Vertex Pharmaceuticals (Europe) Ltd

The largest purchase of all time was on 2018-12-24 and amounted to 136000 shares of CRISPR Therapeutics AG for $3.34M.

Biography of Vertex Pharmaceuticals (Europe) Ltd

No biography is available at this moment.

2018-12-27PurchaseCRISPR Therapeutics AG
CRSP
10 percent owner
54,922
0.1082%
$24.95$1.37M+54.98%
2018-12-27PurchaseVertex Pharmaceuticals Incorporated
VRTX
10 percent owner
27,461
0.0017%
$24.95$685,116+11.51%
2018-12-26PurchaseCRISPR Therapeutics AG
CRSP
10 percent owner
25,474
0.0503%
$24.89$634,155+54.81%
2018-12-26PurchaseVertex Pharmaceuticals Incorporated
VRTX
10 percent owner
12,737
0.0008%
$24.89$317,077+11.73%
2018-12-24PurchaseCRISPR Therapeutics AG
CRSP
10 percent owner
136,000
0.2854%
$24.58$3.34M+66.18%
2018-12-24PurchaseVertex Pharmaceuticals Incorporated
VRTX
10 percent owner
68,000
0.0043%
$24.58$1.67M+18.87%
2018-12-21PurchaseCRISPR Therapeutics AG
CRSP
10 percent owner
45,484
0.0942%
$22.58$1.03M+77.21%
2018-12-21PurchaseVertex Pharmaceuticals Incorporated
VRTX
10 percent owner
22,742
0.0013%
$22.58$513,478+15.13%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.